Objective To investigate the treatment efficacy of recombinant activated factorⅦ(rFⅦa)for bleeding among patients with hematologic disorders.Methods A total of 38 times of bleeding in 31 patients with hematological disease treated with rFⅦa were analyzed retrospectively.Results The clinical effective rate of rFⅦa for bleeding management in acquired hemophilia A(AHA)patients/hemophilia patients with inhibitor,a- Objective To investigate the treatment efficacy of recombinant activated factor VII (rFⅦa) for bleeding among patients with hematologic disorders. Methods A total of 38 times of bleeding in 31 patients with hematological disease treated with rFⅦa were analyzed retrospectively. Results The clinical effective rate of rFⅦa for bleeding management in acquired hemophilia A (AHA) patients / hemophilia patients with inhibitor, a-